H

    Heartflow, Inc. Common Stock (HTFL)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $50.39
    +2.61 (+5.46%)

    Market Cap: $4.15B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    60%(3/5)
    Avg Surprise
    -76.39%
    Streak
    3 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.10
    Range$-0.14 - $-0.08
    8 analysts
    EPS Revisions
    1
    0
    7d
    1
    2
    30d
    EPS Estimate Drift
    90d ago$-0.11-5.6%
    60d ago$-0.11-5.6%
    30d ago$-0.11-5.6%
    7d ago$-0.10+0.0%
    Current$-0.10
    Revenue Consensus
    $65M
    Range$65M - $66M
    8 analysts
    Dec 31, 2026
    EPS Consensus$-0.00
    Range$-0.05 - $0.03
    8 analysts
    Revenue Consensus
    $77M
    Range$76M - $79M
    9 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.00---
    Sep 26EST
    		-$-0.10---
    Jun 26
    		$-0.16$-0.22+27.27%Beat+85.5%
    Mar 26
    		$-0.16$-0.17+5.88%Beat-
    Dec 25
    		$-0.12$-0.15+21.20%Beat-
    Sep 25
    		$-0.27$-0.24-12.50%Miss-
    Jun 25
    		$-1.10$-0.21-423.81%Miss-

    Key Metrics

    Valuation
    P/E Ratio-71.15EV/EBITDAN/A
    Price/FCF-73.56xFCF Yield-1.36%
    Profitability
    Profit Margin-55.80%Operating Margin-27.90%
    ROE-154.20%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio5.08xQuick Ratio5.08x
    Trading Statistics
    BetaN/AAvg Volume2.13M
    52-Week High$51.1952-Week Low$20.13

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$48.26
    SMA 20$39.84
    SMA 50$32.70
    SMA 200$29.54
    EMA 10$46.67
    EMA 20$41.89
    EMA 50$35.50
    EMA 200$30.89

    MACD

    Line: 5.76Signal: 5.03Hist: 0.74

    ADX

    ADX: 52.3+DI: 43.2-DI: 9.2

    Aroon & PSAR

    Aroon Up84.0
    Aroon DownN/A
    PSAR$51.19

    Bollinger Bands

    Upper Band$59.01
    Lower Band$20.68
    %B Position9621%(Upper)
    Band Width0.78

    RSI (14-Day)

    Overbought
    80.9

    Momentum Oscillators

    Stoch %K89.3
    Stoch %D89.1
    Williams %R-3.5
    ROC (10d)20.1%
    Momentum8.45
    CCI (20d)74.8
    MFI (14d)85.5

    Volatility Measures

    ATR (14d)$2.46(4.9%)
    StdDev (20d)9.58
    Hist Vol128.3%(High)

    Volume Flow

    VWAP$49.50
    OBV60.6M
    AD Line7.1M
    CMF (20d)0.261

    Volume Metrics

    Avg Vol (20d)2.2M
    Vol Ratio1.2x
    VWMA (20d)$43.02

    Pivot Points

    R3$49.39
    R2$48.95
    R1$48.36
    Pivot Point$47.92
    S1$47.33
    S2$46.89
    S3$46.30

    Advanced Oscillators

    TSI62.52
    Ultimate Osc58.6
    KST741.67

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    Total Revenue$64.08M$52.59M$49.13M$46.28M$43.42M$37.20M$34.98M$32.93M$31.05M$26.84M
    Cost of Revenue$10.89M$10.42M$10.07M$10.86M$10.65M$9.26M$8.73M$8.00M$7.21M$7.42M
    Gross Profit$53.19M$42.16M$39.06M$35.41M$32.78M$27.94M$26.25M$24.94M$23.84M$19.42M
    Operating Expenses$71.09M$71.67M$56.81M$50.51M$46.49M$45.44M$42.31M$39.87M$38.02M$35.48M
    R&D$26.26M$21.62M$18.66M$17.30M$15.03M$13.92M$12.28M$11.86M$9.93M$9.44M
    SG&A$44.83M$42.57M$38.15M$33.22M$31.46M$31.52M$30.03M$28.00M$28.08M$26.04M
    Operating Income$-17,900,000$-29,504,000$-17,750,000$-15,099,000$-13,715,000$-17,502,000$-16,058,000$-14,929,000$-14,177,000$-16,058,000
    Interest Income$2.31M$2.46M$2.63M$1.73M$635,000$543,000$592,000$820,000$1.14M$1.51M
    Interest Expense$0$3,000$8,000$9.81M$6.62M$5.09M$5.15M$5.30M$6.08M$6.24M
    Income Before Tax$-15,721,000$-27,357,000$-24,560,000$-50,825,000$-9,137,000$-32,345,000$-32,970,000$-19,140,000$-23,259,000$-21,004,000
    Income Tax Expense$22,000$23,000$-165,000$30,000$59,000$0$5,000$0$120,000$-72,000
    Net Income$-15,743,000$-27,380,000$-24,395,000$-50,855,000$-9,196,000$-32,345,000$-32,975,000$-19,140,000$-23,379,000$-20,932,000
    EBITDA$-16,366,000$-28,220,000$-22,306,000$-39,049,000$1.76M$-24,701,000$-25,483,000$-12,449,000$-18,326,000$-12,888,000
    EBIT$-18,026,000$-29,818,000$-24,552,000$-42,739,000$-3,151,000$-27,795,000$-27,818,000$-14,662,000$-18,326,000$-14,761,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about HTFL

    News

    Heartflow CEO John Farquhar sells $1.36m in common stock

    Heartflow CEO John C.M. Farquhar sold 27,230 shares of the company's common stock for $1.36 million at $50.0 per share, executed via a Rule 10b5-1 trading plan. This sale occurred while the stock was near its 52-week high, after a 117% surge, and an InvestingPro analysis indicates the stock is currently overvalued. The company recently reported better-than-expected Q2 2026 results with narrower losses and increased revenue, leading to an analyst price target increase.

    Investing.com•8/26/26•
    Neutral

    HeartFlow Market Sentiment

    This article provides an overview of HeartFlow (HTFL) market sentiment, summarizing key signals such as analyst consensus, short interest, options flow, and insider activity. It highlights an "Overweight" analyst consensus with an average price target of $41, bearish signals from rising short interest and put/call ratio, and net selling by insiders over the last 30 days. The article also lists recent analyst actions with their updated price targets and ratings.

    Benzinga France•8/22/26•
    Somewhat-Bearish

    HeartFlow (NasdaqGS:HTFL) Stock Forecast & Analyst Predictions

    HeartFlow (NasdaqGS:HTFL) is forecast to significantly increase earnings and revenue, with expected growth rates of 54.8% and 19.6% per annum, respectively, though it is projected to remain unprofitable for the next three years. The company has repeatedly raised its earnings guidance for 2026, driven by strong Q1 and Q2 results, adoption of its AI-powered diagnostic tools, and new clinical data supporting its Plaque Analysis platform. Despite recent share price volatility and ongoing insider selling, analysts have adjusted their price targets upwards, reflecting confidence in the company's growth trajectory and expanding market presence in cardiovascular care.

    Simply Wall Street•8/22/26•
    Somewhat-Bullish

    Heartflow (HTFL) insider plans fresh stock sale after option exercise

    Heartflow, Inc. (HTFL) insider John C. M. Farquhar has filed a Form 144 notice to sell 27,230 shares of common stock, valued at approximately $1.36 million, following a stock option exercise on June 24, 2024. The sale will be executed through Fidelity Brokerage Services LLC. The filing also details several prior common stock sales by Farquhar over the last three months, providing transparency on insider trading activities.

    Stock Titan•8/21/26•
    Somewhat-Bearish

    Heartflow CEO John Farquhar sells $1.47 million in company stock

    Heartflow CEO John Farquhar sold 32,676 shares of company stock for approximately $1.47 million on August 18, 2026, as part of a Rule 10b5-1 trading plan. The sale occurred after Heartflow's shares surged over 86% in six months, reaching near a 52-week high. Despite the sale, Farquhar still holds 388,044 shares, and the company recently reported strong Q2 2026 results with revenue exceeding analyst expectations.

    Investing.com•8/21/26•
    Neutral

    Frequently Asked Questions About HTFL

    Does HTFL pay dividends?
    Heartflow, Inc. Common Stock (HTFL) does not currently pay a regular dividend.
    What is HTFL's market cap?
    Heartflow, Inc. Common Stock (HTFL) has a market capitalization of $4.15B with a current stock price of $50.39.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In